Insights
Healthcare growth runs on a new operating model
For most of the last decade, AI in healthcare was sold as an enabler. The companies that win the next phase will treat it as a growth driver. Speed to market, customer engagement at scale, depth of personalization. None of which regulated markets have delivered.
Shared Accountability Is No Accountability
Most established pharma orgs stall at the ownership question before they ever get to the work.
Pharma's AI Retrofit Ceiling
Your pilots work. Something in the cost base moved. And every use case that tries to become the way the company actually operates stalls in the same place - on a decision right, a headcount, a review gate, or a definition of done. That limit has a name.